New Cancer Vaccine Introduced To The Local Market

A new Cancer Vaccine which can prevent the Cervical Cancer which is the second commonest Cancer among Sri Lankan Women was introduced to the market this evening.At a function held in Colombo Hilton this evening GSK Pharmaceuticals introduced "Cervarix" Canver Vaccine which is acting as an Immunization Vaccine.


The Vaccine which is available for Rs.5950 per vial was launched under the approval of National Drug Authority.According to the Oncologists around 1252 Cervical Cancer Patients are reported from Sri Lanka annually and among them 625 patients died .The newly introduced vaccine is recommended for the girls above 10 years and  women.